Mastering Diabetes Study

November 20, 2024 updated by: David Drozek, Ohio University

Effectiveness of a Virtual Therapeutic Lifestyle Change Program for Diabetes and Prediabetes

This is a program evaluation that will evaluate the effectiveness of Mastering Diabetes, a therapeutic lifestyle change (TLC) program to control prediabetes and type 2 diabetes.

Lifestyle change, focused on dietary change, physical activity, stress management and control of unhealthy substances has been demonstrated effective in preventing the progression of prediabetes, as well as reversal of diabetes and type 2 diabetes mellitus (T2DM).

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

This will be a nonrandomized controlled study. Participants will self select to be a part of this intervention. The control data will be aggregated matched data from participants in the corporate wellness program at Memorial Health System, who choose not to participate in the intervention.

Study participants will have met the inclusion criteria. Potential participants will be provided with a short summary of this program as a potential activity for their participation, with a link leading to a landing page, which will explain the study in more detail, and will include a link to the consent.

If the potential participant is interested, they can click the link to move to the on line consent. If they agree to the consent, they will be taken to an on line HIPAA release form, which will also need an electronic agreement to be enrolled into the study signified by typing in the participant's name and date of birth.

Once this is completed, an email with an enrollment code and link to Mastering Diabetes will be sent the participant.

Mastering Diabetes Program Description:

The Mastering Diabetes Program is based on the Mastering Diabetes Method, which is based on almost 100 years of evidence based research demonstrating the effectiveness of a low-fat, plant-based, whole-food diet to reverse insulin resistance. Members are provided with a step-by-step online course that educates them how to transition to a low-fat, plant-based, whole-food lifestyle and reduce the overwhelm associated with ineffective pharmaceutical medication and ineffective dietary advice.

The online course provides members with detailed information about the root cause of insulin resistance, the effect of a high-fat diet on increasing insulin resistance, how to achieve excellent blood glucose values in the short-term and in the long-term, what laboratory tests to get to measure progress, an overview of oral diabetes medication and insulin, how to track hour-by-hour decisions for excellent blood glucose control, how to lose weight permanently using a low-fat, plant-based, whole-food diet, how to buy food, where to buy food, how to prepare food easily, the benefits of intermittent fasting for improved insulin sensitivity, how to perform an intermittent fast for excellent results, how to adopt an exercise regimen, how to control your blood glucose before, during, and after exercise, how to change your breakfast, lunch, dinner, and also provides members with a collection of delicious and simple recipes.

The program also provides members with direct access to expert coaches via an online community containing thousands of others living with all forms of diabetes, including type 1 diabetes, type 1.5 diabetes, prediabetes, type 2 diabetes, and gestational diabetes. In addition, members get access to live biweekly Q&A videoconferences in which they can interact with coaches and personalize their experience. The cost of full coaching program is $399 for the first 3 months, then $99 per month thereafter.

Participants, having enrolled in the wellness program, will already, as a part of that study, have agreed to have data collected at baseline and yearly thereafter, including BMI, blood pressure, resting pulse, lipid panel, hemoglobin A1c, health risk assessment survey, absenteeism and health claims data at baseline and yearly thereafter. If not collected within 60 days, a new set of data will be collected to serve as baseline for this study. This is not specific for this study, but is the case for any new program activity that a participant in the corporate wellness study begins.

Specifically for this study the health risk assessment data collection (including lab analysis) will also be repeated at 12 weeks. The lab work is accomplished at any MHS lab facility, according to current medical system standards.

Participant health claims data will also be evaluated, beginning with the prior year's data, if available from MHS Human Resources, being utilized as a baseline, and followed for the subsequent years of the study.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Athens, Ohio, United States, 45701
        • Ohio University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18-75 years at enrollment
  • Has a diagnosis of diabetes or prediabetes or a HbA1c of 5.7 or higher.
  • Are able to participate in physical activity.
  • Are willing to use a smartphone or computer to access the online education modules and online community, and have reliable daily Internet access with a device with a webcam
  • Have an email account and an Internet connection at home
  • Are able to purchase and transport fresh produce from a local grocery store to their house on a weekly basis
  • Are able to prepare food in their house or get help preparing food in their house following recipes and meal examples provided in the online course
  • Are open-minded about eating a plant-based diet, performing periodic intermittent fasting (16-24 hours, once a week),
  • Are willing to increase movement of their body 5-6 days per week
  • Are willing to participate in an online community for support and coaching
  • Are willing to participate in biweekly videoconferencing for support and coaching
  • Are willing to be courteous and respectful to others in the online community

Exclusion Criteria:

  • Has been told by a medical provider to not participate in physical activity.
  • Has a medical condition that prevents walking at least a mile a day.
  • Deemed unsuitable to exercise by Dr. Drozek or other members of the wellness team.
  • Has a diagnosis of dementia.
  • Is pregnant or planning to become pregnant during the program
  • Does not speak or understand English
  • Advanced renal disease (stage 4 or 5) with or without hemodialysis
  • Congestive heart failure
  • Has inflammatory bowel disease (Crohns disease, ulcerative colitis)
  • Is fed by a feeding tube
  • Is taking Coumadin or warfarin
  • Inability to use email, a smartphone, or the Internet

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mastering Diabetes
Adults (hospital employees, their spouses, and community members) who have been identified as having diabetes or prediabetes based on a health risk assessment, who have chosen to participate in Mastering Diabetes. They may or may not be receiving additional usual care.
Virtual (on-line) lifestyle change program, focused on a plant-based, whole food diet and physical activity.
No Intervention: Usual care
Employees and spouses of the hospital system who are participating in the employee wellness program, who have been identified as having diabetes or prediabetes based on a health risk assessment, who have chosen not to participate in Mastering Diabetes. They may or may not be receiving additional usual care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HbA1c
Time Frame: up to 20 years
glycosylated hemoglobin measured from venous blood
up to 20 years
BMI
Time Frame: up to 20 years
Body mass index calculated from height and weight
up to 20 years
Healthcare expenditures
Time Frame: up to 20 years
Monetary amount spent for healthcare
up to 20 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total cholesterol
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Measured from a lipid panel done on venous blood
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Low density lipoprotein cholesterol
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Calculated from a lipid panel done on venous blood
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
High density lipoprotein cholesterol
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Measured from a lipid panel done on venous blood
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Triglyceride
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Measured from a lipid panel done on venous blood
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Exercise level
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Amount of time spent per week in moderate to vigorous physical activity
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Dietary Recall
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Daily or weekly average of foods consumed during the last 7 days
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Patient Health Questionnaire
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
mood screening questions; two for anxiety
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
Patient Health Questionnaire
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
mood screening questions; two for depression.
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 24, 2020

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

June 29, 2020

First Submitted That Met QC Criteria

July 1, 2020

First Posted (Actual)

July 2, 2020

Study Record Updates

Last Update Posted (Estimated)

November 22, 2024

Last Update Submitted That Met QC Criteria

November 20, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on Mastering Diabetes

Subscribe